**Author details**

Syed Manzoor Kadri1 \*, Marija Petkovic2 , Arshi Taj3 and Ailbhe H. Brady4

1 Disease Control, Directorate of Health Services, Kashmir, India

2 University of Medicine, Belgrade, Serbia

3 Department of Anaesthesia, Critical Care and Pain Management, Government Medical College, Srinagar, Kashmir, India

4 Warrington and Halton Teaching Hospitals NHS Foundation Trust, Intensive Care Department, Warrington, United Kingdom

\*Address all correspondence to: kadrism@gmail.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**167**

*Leprosy in the Modern Era*

**References**

2016−2020

2018

2004;**30**(4):393-409

2007;**44**(8):1096-1099

*DOI: http://dx.doi.org/10.5772/intechopen.91450*

[1] Ghosh S, Chaudhuri S. Chronicles of Gerhard-Henrik Armauer Hansen's life and work. Indian Journal of Dermatology. 2015;**60**(3):219-221

et Biophysica Acta. 2017;**1864**:746-757. DOI: 10.1016/j.bbadis.2017.12.023

[10] de Souza Aarão TL, de Sousa JR, Falcão ASC, Falcão LFM, Quaresma JAS. Nerve growth factor and pathogenesis of leprosy: Review and update. Frontiers

[11] Scollard DM, Adams LB, Gillis TP, Krahenbuhl JL, Truman RW, Williams DL. The continuing challenges of leprosy. Clinical Microbiology Reviews.

[12] Lastória JC, de Abreu MAMM. Leprosy: A review of laboratory and therapeutic aspects - part 2. Anais Brasileiros de Dermatologia. The Brasilian Society of Dermatology.

[13] Fischer M. Leprosy – An Overview of Clinical Features, Diagnosis, and Treatment. Wiley Online Libraries; 2017

[14] White C, Franco-Paredes C. Leprosy

Microbiology Reviews. 2015;**28**(1):80-94

[15] Misch EA, Berrington WR, Vary JC Jr, Hawn TR. Leprosy and the human genome. Microbiology and Molecular Biology Reviews. December

[16] Spencer JS, Brennan PJ. The role of *mycobacterium leprae* phenolic glycolipid

I (PGL-I) in serodiagnosis and in the pathogenesis of leprosy. Leprosy

Review. 2011;**82**(4):344-357

in the 21st century. Clinical

in Immunology. 2018;**9**:939

2006;**19**(2):338-381

2014;**89**(3):389-401

2010;**74**(4):589-620

[2] World Health Organization. Leprosy: Fact Sheet 101. 2015. Operational Manual – Global Leprosy Strategy

[3] Antunes SL, Chimelli LM, Rabello ET, Valentim VC, Corte-Real S, Sarno EN, et al. An immunohistochemical, clinical and electroneuromyographic correlative study of the neural markers in the neuritic form of leprosy. Brazilian Journal of Medical and Biological Research. 2006;**39**(8):1071-1081

[4] Cambri G, Mira MT. Genetic susceptibility to leprosy—From classic immune-related candidate genes to hypothesis-free, whole genome approaches. Frontiers in Immunology.

[5] Ooi WW, Srinivasan J. Leprosy and the peripheral nervous system: Basic and clinical aspects. Muscle & Nerve.

[6] Pardillo FE, Fajardo TT, Abalos RM, Scollard D, Gelber RH. Methods for the classification of leprosy for treatment purposes. Clinical Infectious Diseases.

[7] Chapman SJ, Hill AVS. Human genetic susceptibility to infectious disease. Nature Reviews. Genetics. 2012;**13**(3):175-188

[9] Mohamed R, Coucha M, Elshaer SL, Artham S, Lemtalsi T, El-Remessy AB. Inducible overexpression of endothelial proNGF as a mouse model to study microvascular dysfunction. Biochimica

[8] Anand P. Neurotrophic factors and their receptors in human sensory neuropathies. Progress in Brain Research. 2004;**146**:477-492
